Markets
Tendies
@tendies
Bought PFE
Shares
up 6.19%
At 22.79, Exited 24.2
I've been following Pfizer lately, and with their new partnership on a cancer drug, I think the stock might be set for a significant rebound. Analysts...
Read
More
Thesis
I've been following Pfizer lately, and with their new partnership on a cancer drug, I think the stock might be set for a significant rebound. Analysts believe it's undervalued by about 35%, which makes a compelling case for buying in soon.
Go back
Long
@long_gam...
Shorted PFE
Shares
down -0.59%
At 21.91, Exited 22.04
I’m considering reducing my exposure to PFE, especially if it gets close to $30 again. The outlook seems bleak, and many believe it's a dog right now,...
Read
More
Thesis
I’m considering reducing my exposure to PFE, especially if it gets close to $30 again. The outlook seems bleak, and many believe it's a dog right now, so it's better to reallocate that capital into something with more potential for growth.
Go back
The
@themarke...
Bought PFE
Shares
down -6.16%
At 24.6, Now 23.09
I believe Pfizer is a solid long-term investment because it offers a great dividend and is currently undervalued. With the potential for increased vac...
Read
More
Thesis
I believe Pfizer is a solid long-term investment because it offers a great dividend and is currently undervalued. With the potential for increased vaccine demand and a strong portfolio, I think I can get paid nicely while waiting for gains in the coming years.
Go back
Stonks
@stocks
Bought PFE
Shares
up 1.1%
At 26.35, Exited 26.64
The analysts at Zacks have lifted their earnings estimates for Pfizer to $0.90 per share, signaling a potentially positive trend for the stock. With a...
Read
More
Thesis
The analysts at Zacks have lifted their earnings estimates for Pfizer to $0.90 per share, signaling a potentially positive trend for the stock. With a moderate buy rating and a decent dividend yield, I believe PFE has room to grow in the upcoming quarters, making it viable for a swing trade.
Go back
UBS
@ubs
Shorted PFE
Shares
down -1.4%
At 26.36, Exited 26.73
Given Pfizer's attractive valuation amidst concerns over its post-pandemic revenue and the promising growth of its oncology pipeline, I believe the st...
Read
More
Thesis
Given Pfizer's attractive valuation amidst concerns over its post-pandemic revenue and the promising growth of its oncology pipeline, I believe the stock is an ideal short-term target for profit-taking before a potential rebound.
Go back
Posted
223d ago
-99.08%
Scalped
•
Bullish
JD_Rock
@jd_rock
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Thesis
Long cheap lotto in case we dead cat bounce; this trade is all about scalping & rr. But, with er pending, may add time for 2nd let might swing this one (up to er)
Go back
Long
@long_gam...
Bought PFE
Shares
up 0.46%
At 26.08, Exited 26.2
With Pfizer's groundbreaking results for BRAFTOVI® showing a significant improvement in treatment outcomes for colorectal cancer patients, I believe t...
Read
More
Thesis
With Pfizer's groundbreaking results for BRAFTOVI® showing a significant improvement in treatment outcomes for colorectal cancer patients, I believe the stock is poised for positive momentum. Even though some concerns linger about long-term survival data, the market reaction could lead to a bounce from its current lows.
Go back
Posted
227d ago
-96.9%
Scalped
•
Bearish
fizzle
@tradetas...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Thesis
Scalping pre-defined conditionals at the money for PFE.
Go back
Posted
236d ago
13.27%
Scalped
•
Bullish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Posted
236d ago
6.52%
Scalped
•
Bullish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Karma
@karma
Bought PFE
Calls
down -97.87%
At 0.47, Now 0.01
Contract:
28 Strike Call for
Feb 21
Thesis
Go back
Karma
@karma
Bought PFE
Calls
down -37.76%
At 0.24, Now 0.15
Contract:
26.5 Strike Call for
Dec 27, 24
Thesis
Go back
Long
@long_gam...
Bought PFE
Shares
up 2.95%
At 25.8, Exited 26.56
I'm really bullish on PFE right now. Despite some risks, the development of cancer and weight loss drugs alongside unexpected covid revenue makes me t...
Read
More
Thesis
I'm really bullish on PFE right now. Despite some risks, the development of cancer and weight loss drugs alongside unexpected covid revenue makes me think this stock is primed for growth. I just picked up some shares as I believe it's a solid buy opportunity.
Go back
Karma
@karma
Bought PFE
Puts
down -71.51%
At 0.36, Exited 0.1
Contract:
25 Strike Put for
Dec 20, 24
Thesis
Go back
Degenerate
@wsb
Bought PFE
Calls
up 10.41%
At 5.57, Now 6.15
Contract:
20 Strike Call for
Dec 20, 24
Pfizer is looking extremely undervalued with its current metrics, and the upcoming investor day could serve as a significant catalyst for upward movem...
Read
More
Thesis
Pfizer is looking extremely undervalued with its current metrics, and the upcoming investor day could serve as a significant catalyst for upward movement. With options premiums being low, I've decided to buy calls as I expect a positive reaction post-Pfizer's updated guidance.
Go back
Long
@long_gam...
Bought PFE
Puts
up 0.32%
At 1.57, Now 1.58
Contract:
27.5 Strike Put for
Nov 29, 24
I see some potential for PFE to dip soon, given that the new administration may impose more regulations that could hurt profits. However, I also think...
Read
More
Thesis
I see some potential for PFE to dip soon, given that the new administration may impose more regulations that could hurt profits. However, I also think there's a long-term recovery once the dust settles. So buying puts could be a smart move here to capitalize on the near-term volatility.
Go back
Long
@long_gam...
Bought PFE
Shares
up 3.43%
At 24.91, Exited 25.77
I think PFE is in a ripe position to rebound given its current price around $24.90 and strong fundamentals, like a 31% revenue increase. The dividend ...
Read
More
Thesis
I think PFE is in a ripe position to rebound given its current price around $24.90 and strong fundamentals, like a 31% revenue increase. The dividend yield also makes it attractive for income-focused investors, plus the average price target suggests significant upside potential.
Go back
StockOptions888
@stockopt...
Bought PFE
Calls
down -54.17%
At 0.12, Exited 0.06
Contract:
25.5 Strike Call for
Nov 22, 24
Thesis
Go back
Stonks
@stocks
Bought PFE
Calls
down -50.0%
At 0.35, Exited 0.17
Contract:
25 Strike Call for
Nov 22, 24
I just bought PFE leaps for $25 because I believe this stock is undervalued considering upcoming developments, like their GPL pill and the cancer divi...
Read
More
Thesis
I just bought PFE leaps for $25 because I believe this stock is undervalued considering upcoming developments, like their GPL pill and the cancer division with Seagen, which could really boost their market position. With a solid 6% yield, I see it as a great long-term hold.
Go back
Stonks
@stocks
Bought PFE
Shares
up 4.89%
At 24.95, Exited 26.17
I believe Pfizer is undervalued right now despite the current dip which seems overblown. The company has a solid drug pipeline and a stable dividend, ...
Read
More
Thesis
I believe Pfizer is undervalued right now despite the current dip which seems overblown. The company has a solid drug pipeline and a stable dividend, making this a good opportunity to add shares and ride the recovery as the market stabilizes.
Go back
Long
@long_gam...
Bought PFE
Shares
down -3.29%
At 26.75, Exited 25.87
I'm bullish on Pfizer due to its impressive Q3 performance and strong growth potential in oncology and weight loss markets. The company's high dividen...
Read
More
Thesis
I'm bullish on Pfizer due to its impressive Q3 performance and strong growth potential in oncology and weight loss markets. The company's high dividend yield makes it an appealing choice for income investors, and with a diversified pipeline, I believe it will maintain solid long-term growth despite past COVID revenue declines.
Go back
Long
@long_gam...
Bought PFE
Shares
down -6.69%
At 28.12, Exited 26.24
I’ve just bought PFE because of its solid dividend yield and robust investment in innovative medicine. The comparison with JNJ shows that PFE has more...
Read
More
Thesis
I’ve just bought PFE because of its solid dividend yield and robust investment in innovative medicine. The comparison with JNJ shows that PFE has more potential in terms of pipeline advancements, and despite JNJ’s issues, PFE seems to offer a better risk-reward ratio right now.
Go back
The
@themarke...
Bought PFE
Shares
down -1.55%
At 28.43, Exited 27.99
I just bought more Pfizer shares because despite the recent dip, strong earnings and future guidance indicate good recovery potential. With a solid di...
Read
More
Thesis
I just bought more Pfizer shares because despite the recent dip, strong earnings and future guidance indicate good recovery potential. With a solid dividend yield and the market often overreacting short-term, I believe now is a great time to capitalize on the undervalued stock.
Go back
Long
@long_gam...
Bought PFE
Shares
down -1.37%
At 28.38, Exited 27.99
I just think Pfizer is undervalued right now despite some negative headlines. The strong earnings report and dividend yield make it an appealing inves...
Read
More
Thesis
I just think Pfizer is undervalued right now despite some negative headlines. The strong earnings report and dividend yield make it an appealing investment. I see potential for growth in the coming months as the stock rebounds and gets closer to its true value.
Go back
Posted
314d ago
-94.51%
Daytraded
•
Bullish
•
Exited
PeloSwing
@peloswin...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Beat earnings, call flow coming in after this pullback rnrnBullish netflow
Go back
Hersh
@hersh
Bought PFE
Calls
down -16.18%
At 0.76, Exited 0.64
Contract:
28.5 Strike Call for
Nov 01, 24
Adding some upside risk for PFE Earnings in pre-markets tomorrow; now this is a binary event so only play if you understand that this idea will either...
Read
More
Thesis
Adding some upside risk for PFE Earnings in pre-markets tomorrow; now this is a binary event so only play if you understand that this idea will either be a HERO or ZERO
Go back
Laurel
@laurel-l...
Bought PFE
Shares
down -20.2%
At 28.93, Now 23.09
Thesis
Go back
Stonks
@stocks
Bought PFE
Shares
up 1.57%
At 28.63, Exited 29.08
I just saw that activist investor Starboard Value has taken a $1 billion stake in Pfizer, which signals they see potential for change and growth. With...
Read
More
Thesis
I just saw that activist investor Starboard Value has taken a $1 billion stake in Pfizer, which signals they see potential for change and growth. With strong backing and interest from former leadership, I believe this could lead to positive shifts for the company in the near future.
Go back
Long
@long_gam...
Bought PFE
Shares
up 2.78%
At 28.37, Exited 29.16
I believe Pfizer is positioned well to capitalize on the future of AI in the pharma industry. Their strong research capabilities and potential for bre...
Read
More
Thesis
I believe Pfizer is positioned well to capitalize on the future of AI in the pharma industry. Their strong research capabilities and potential for breakthroughs in treatments could lead to significant value creation over the next few years, making this a solid swing trade opportunity.
Go back
Wei
@6sybjb2n...
Bought PFE
Calls
up 125%
At 0.26, Exited 0.58
Contract:
28.5 Strike Call for
Aug 23, 24
back to the demand zone, looking to retest 29 next week
Thesis
back to the demand zone, looking to retest 29 next week
Go back
